Alligator Bioscience Logo

Alligator Bioscience

ATORX | ST

Overview

Corporate Details

ISIN(s):
SE0000767188 (+8 more)
LEI:
549300E15VI0MB7LXV19
Country:
Sweden
Address:
C/O Medicon Village, 223 81 Lund
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Alligator Bioscience is a clinical-stage biotechnology company focused on developing tumor-directed immuno-oncology antibody drugs. The company specializes in creating antibody-based pharmaceuticals for cancer treatment, with a primary focus on activating the CD40 receptor pathway to stimulate a patient's immune system against tumors. Its lead candidate, mitazalimab, is a CD40 agonist in late-stage clinical development for pancreatic cancer. Alligator Bioscience's business model is centered on advancing its pipeline of novel drug candidates through discovery, preclinical, and clinical development stages to commercialization.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Alligator Bioscience. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-27 21:00
Share Issue/Capital Change
Exercise price determined for the exercise of warrants series TO 13 in Alligato…
English 72.6 KB
2025-08-27 21:00
Share Issue/Capital Change
Teckningskurs fastställd för nyttjandet av teckningsoptioner serie TO 13 i Alli…
Swedish 72.8 KB
2025-07-21 12:18
Major Shareholding Notification
Swedish 10.9 KB
2025-07-17 11:38
Major Shareholding Notification
Swedish 10.9 KB
2025-07-10 10:49
Major Shareholding Notification
Swedish 10.9 KB
2025-07-10 08:00
Interim Report
Swedish 1.2 MB
2025-07-10 08:00
Interim Report
English 1.2 MB
2025-06-30 15:00
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Alligator Bioscience AB
Swedish 54.8 KB
2025-06-30 15:00
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Alligator Bioscience AB
English 54.1 KB
2025-06-26 10:21
Major Shareholding Notification
Swedish 9.9 KB
2025-06-25 10:35
Major Shareholding Notification
Swedish 11.1 KB
2025-06-23 14:35
Major Shareholding Notification
Swedish 11.1 KB
2025-06-19 10:42
Major Shareholding Notification
Swedish 11.1 KB
2025-06-11 11:33
Major Shareholding Notification
Swedish 11.1 KB
2025-06-09 12:10
Major Shareholding Notification
Swedish 10.6 KB

Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alligator Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-28 Peter Ostler Other Sell 1,658,134 179,045.31 SEK
2024-04-11 Staffan Encrantz Other Sell 44,108,581 47,196,181.67 SEK
2022-10-27 Sören Bregenholt Frederiksen Other Buy 52,000 72,748.00 SEK
2022-10-25 Marie Svensson Other Buy 12,000 16,632.00 SEK
2022-08-19 Sören Bregenholt Frederiksen Other Buy 13,906 25,726.10 SEK
2022-08-18 Sören Bregenholt Frederiksen Other Buy 31,094 56,911.35 SEK
2022-05-31 Peter Ostler Other Buy 100,000 151,500.00 SEK
2022-05-04 Sören Bregenholt Frederiksen Other Buy 30,000 50,895.00 SEK
2022-05-02 Sören Bregenholt Frederiksen Other Buy 30,000 50,811.00 SEK
2022-04-30 Sören Bregenholt Frederiksen Other Buy 30,000 51,171.00 SEK

Peer Companies

Company Country Ticker View
ARIX BIOSCIENCE PLC Logo United Kingdom ARIX
AroCell AB Logo Sweden AROC
Arterra Bioscience Logo
Develops sustainable active ingredients from plant cell cultures for diverse industries.
Italy ABS
Asarina Pharma AB Logo
Developed Sepranolone for neurological disorders like Tourette's, OCD, and menstrual migraine.
Sweden ASAP
Ascelia Pharma Logo
Developing novel drugs for rare cancer conditions, including an oral MRI contrast agent.
Sweden ACE
AVACTA GROUP PLC Logo
Developing targeted cancer therapies with a platform that delivers drugs directly to tumors.
United Kingdom AVCT
BenevolentAI Logo
AI-powered platform that analyzes biomedical data to accelerate drug discovery.
United Kingdom BAI
BerGenBio Logo
Develops first-in-class AXL inhibitors for cancer and severe respiratory infections.
Norway BGBIO
BioArctic Logo
Biopharma developing treatments & diagnostics for neurodegenerative diseases like Alzheimer's.
Sweden BIOA
Biophytis S.A. Logo
Develops oral drugs for age-related neuromuscular, retinal, and metabolic diseases.
France ALBPS